GlaxoSmithKline Pharmaceuticals · NSE: GLAXO · BSE: 500660
Q2 FY19 results · Jul–Sep 2018
GlaxoSmithKline Pharmaceuticals reported revenue from operations of ₹816.31 crore and net profit of ₹100.77 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 816.31 | — | — | 735.65 | +11.0% |
| Other income | 14.82 | — | — | 17.78 | −16.6% |
| Total income | 831.13 | — | — | 753.43 | +10.3% |
| Profit before tax | 156.46 | — | — | 138.31 | +13.1% |
| Net profit for the period | 100.77 | — | — | 88.59 | +13.7% |
| EPS, basic (₹) | 5.95 | — | — | 10.46 | not comparable |
| Net margin (%) | 12.3 | — | 12.0 |
Standalone
- Filed with BSE
- 22 Oct 2018, 18:19 IST
- Board meeting
- 22 Oct 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE